Systemic inflammation affects reperfusion following transient cerebral ischaemia

Experimental Neurology

Volumn 277, Issue , 2016, Pages 252-260

  Burrows, F ^a   Haley, M J ^a   Scott, E ^a   Coutts, G ^a   Lawrence, C B ^a   Allan, S M ^a   Schiessl, I ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Co morbidity; Interleukin 1; Interleukin 1 ; Middle cerebral artery occlusion; Optical imaging; Reperfusion; Spectroscopy; Stroke; Systemic inflammation

Indexed keywords

FIBRINOGEN RECEPTOR; INTERLEUKIN 1ALPHA; OXYHEMOGLOBIN; ACTIN BINDING PROTEIN; AIF1 PROTEIN, MOUSE; CALCIUM BINDING PROTEIN; INTERLEUKIN 1; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL ACTIVATION; DISEASE EXACERBATION; INFLAMMATION; MALE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REPERFUSION; SYSTEMIC DISEASE; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; CEREBRAL ARTERY DISEASE; COMPLICATION; DISEASE MODEL; DRUG EFFECT; HEMISPHERIC DOMINANCE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPECTROSCOPY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTOR;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD; CALCIUM-BINDING PROTEINS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; FUNCTIONAL LATERALITY; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERLEUKIN-1; MALE; MICE; MICE, INBRED C57BL; MICROFILAMENT PROTEINS; OXYHEMOGLOBINS; REPERFUSION; SPECTRUM ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS;

EID: 84955260809     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2016.01.013     Document Type: Article

References (43)

1. Afshar-Kharghan V., Thiagarajan P. Leukocyte adhesion and thrombosis. Curr. Opin. Hematol. 2006, 13(1):34-39.
2. Allen C., Thornton P., Denes A., McColl B.W., Pierozynski A., Monestier M., Pinteaux E., Rothwell N.J., Allan S.M. Neutrophil cerebrovascular transmigration triggers rapid neurotoxicity through release of proteases associated with decondensed DNA. J. Immunol. 2012, 189(1):381-392.
3. Ankolekar S., Rewell S., Howells D.W., Bath.P.M.W. The influence of stroke risk factors and comorbidities on assessment of stroke therapies in humans and animals. Int. J. Stroke 2012, 7(5):386-397.
4. Berwick J., Johnston D., Jones M., Martindale J., Redgrave P., McLoughlin N., Schiessl I., Mayhew J.E.W. Neurovascular coupling investigated with two-dimensional optical imaging spectroscopy in rat whisker barrel cortex. Eur. J. Neurosci. 2005, 22(7):1655-1666.
5. Bottcher M., Falk E. Pathology of the coronary arteries in smokers and non-smokers. J. Cardiovasc. Risk 1999, 6(5):299-302.
6. Brandolini L., Sergi R., Caselli G., Boraschi D., Locati M., Sozzani S., Bertini R. Interleukin-1 beta primes interleukin-8-stimulated chemotaxis and elastase release in human neutrophils via its type I receptor. Eur. Cytokine Netw. 1997, 8(2):173-178.
7. Brown J.K., Pemberton A.D., Wright S.H., Miller H.R.P. Primary antibody-Fab fragment complexes: a flexible alternative to traditional direct and indirect immunolabeling techniques. J. Histochem. Cytochem. 2004, 52(9):1219-1230.
8. Burrows F.E., Bray N., Denes A., Allan S.M., Schiessl I. Delayed reperfusion deficits after experimental stroke account for increased pathophysiology. J. Cereb. Blood Flow Metab. 2015, 35(2):277-284.
9. Cramer T., Yamanishi Y., Clausen B.E., Forster I., Pawlinski R., Mackman N., Haase V.H., Jaenisch R., Corr M., Nizet V., Firestein G.S., Gerber H.P., Ferrara N., Johnson R.S. Hif-1 alpha is essential for myeloid cell-mediated inflammation. Cell 2003, 112(5):645-657.
10. Del Zoppo G.J., Schmid-Schonbein G.W., Mori E., Copeland B.R., Chang C.M. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 1991, 22(10):1276-1283.
11. Denes A., Humphreys N., Lane T.E., Grencis R., Rothwell N. Chronic systemic infection exacerbates ischemic brain damage via a Ccl5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice. J. Neurosci. 2010, 30(30):10086-10095.
12. Denes A., Thornton P., Rothwell N.J., Allan S.M. Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav. Immun. 2010, 24(5):708-723.
13. Denes A., Ferenczi S., Kovacs K.J. Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood-brain barrier damage and brain oedema independently of infarct size. J. Neuroinflammation 2011, 8.
14. Denes A., Pradillo J.M., Drake C., Sharp A., Warn P., Murray K.N., Rohit B., Dockrell D.H., Chamberlain J., Casbolt H., Francis S., Martinecz B., Nieswandt B., Rothwell N.J., Allan S.M. Streptococcus pneumoniae worsens cerebral ischemia via interleukin 1 and platelet glycoprotein Ibα. Ann. Neurol. 2014 May, 75(5):670-683.
15. Doyle K.P., Simon R.P., Stenzel-Poore M.P. Mechanisms of ischemic brain damage. Neuropharmacology 2008, 55(3):310-318.
16. Emsley H.C.A., Smith C.J., Georgiou R.F., Vail A., Hopkins S.J., Rothwell N.J., Tyrrell P.J., I.L-1ra Acute Stoke Investigators A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J. Neurol. Neurosurg. Psychiatry 2005, 76(10):1366-1372.
17. Emsley H.C.A., Smith C.J., Tyrrell P.J., Hopkins S.J. Inflammation in acute ischemic stroke and its relevance to stroke critical care. Neurocrit. Care. 2008, 9(1):125-138.
18. Engel O., Kolodziej S., Dirnagl U., Prinz V. Modeling stroke in mice - middle cerebral artery occlusion with the filament model. J. Vis. Exp. 2011, 47.
19. Ericsson A., Liu C., Hart R.P., Sawchenko P.E. Type-1 interleukin-1 receptor in the rat-brain - distribution, regulation, and relationship to sites of Il-1-induced cellular activation. J. Comp. Neurol. 1995, 361(4):681-698.
20. Gawaz M., Brand K., Dickfeld T., Pogatsa-Murray G., Page S., Bogner C., Koch W., Schomig A., Neumann F.J. Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atherosclerosis 2000, 148(1):75-85.
21. Grau A.J., Buggle F., Heindl S., Steichenwiehn C., Banerjee T., Maiwald M., Rohlfs M., Suhr H., Fiehn W., Becher H., Hacke W. Recent infection as a risk factor for cerebrovascular ischemia. Stroke 1995, 26(3):373-379.
22. Herz J., Sabellek P., Lane T.E., Gunzer M., Hermann D.M., Doeppner T.R. Role of neutrophils in exacerbation of brain injury after focal cerebral ischemia in hyperlipidemic mice. Stroke 2015, 46(10):2916-2925.
23. Lloyd J. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee (Vol 119, Pg E21, 2009). Circulation 2010, 122(1):E11-E11.
24. Lu Q.L., Partridge T.A. A new blocking method for application of murine monoclonal antibody to mouse tissue sections. J. Histochem. Cytochem. 1998, 46(8):977-983.
25. Maysami S., Haley M.J., Gorenkova N., Krishnan S., McColl B.W., Lawrence C.B. Prolonged diet-induced obesity in mice modifies the inflammatory response and leads to worse outcome after stroke. J. Neuroinflammation 2015 Aug 4, 12:140.
26. McColl B.W. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J. Neurosci. 2008, 28(38):9451-9462.
27. McColl B.W. Systemic infection, inflammation and acute ischemic stroke. Neuroscience 2009, 158(3):1049-1061.
28. McColl B.W., Allan S.M., Rothwell N.J. Systemic inflammation and stroke: aetiology, pathology and targets for therapy. Biochem. Soc. Trans. 2007, 35:1163-1165.
29. McColl B.W., Rothwell N.J., Allan S.M. Systemic inflammatory stimulus potentiates the acute phase and Cxc chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J. Neurosci. 2007, 27(16):4403-4412.
30. McColl B.W., Rose N., FH R., NJ R., CB L. Increased brain microvascular MMP-9 and incidence of haemorrhagic transformation in obese mice after experimental stroke. J. Cereb. Blood Flow Metab. 2010 Feb, 30(2):267-272.
31. Mirlashari M.R., Hagberg I.A., Lyberg T. Platelet-platelet and platelet-leukocyte interactions induced by outer membrane vesicles from N. meningitidis. Platelets 2002, 13(2):91-99.
32. Mori E., Delzoppo G.J., Chambers J.D., Copeland B.R., Arfors K.E. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral-ischemia in baboons. Stroke 1992, 23(5):712-718.
33. Murray K.N., Buggey H.F., Denes A., Allan S.M. Systemic immune activation shapes stroke outcome. Mol. Cell. Neurosci. 2013, 53:14-25.
34. Murray K.N., Parry-Jones A.R., Allan S.M. Interleukin-1 and acute brain injury. Front. Cell. Neurosci. 2015, 9:18.
35. Nielsen B., Borupchristensen P., Erb K., Jensenius J.C., Husby S. A method for the blocking of endogenous immunoglobulin on frozen tissue-sections in the screening of human hybridoma antibody in culture supernatants. Hybridoma 1987, 6(1):103-109.
36. Pinto A., Tuttolomondo A., Raimondo D.D., Fernandez P., Licata G. Cerebrovascular risk factors and clinical classification of strokes. Semin. Vasc. Med. 2004, 4(3):287-303.
37. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., Hailpern S.M., Ho M., Howard V., Kissela B., Kittner S., Lloyd-Jones D., McDermott M., Meigs J., Moy C., Nichol G., O'Donnell C., Roger V., Sorlie P., Steinberger J., Thom T., Wilson M., Hong Y., Stroke Amer Heart Assoc Stat Comm Heart disease and stroke statistics - 2008 update - a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117(4):E25-E146.
38. Semenza G.L. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology 2009, 24(2):97-106.
39. Smeeth L., Thomas S.L., Hall A.J., Hubbard R., Farrington P., Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N. Engl. J. Med. 2004, 351(25):2611-2618.
40. Smith C.J., Emsley H.C.A., Gavin C.M., Georgiou R.F., Vail A., Barberan E.M., Zoppo G.J.d., Hallenbeck J.M., Rothwell N.J., Hopkins S.J., Tyrrell P.J. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 2004, 4.
41. Thornton P., McColl B.W., Greenhalgh A., Denes A., Allan S.M., Rothwell N.J. Platelet interleukin-1 alpha drives cerebrovascular inflammation. Blood 2010, 115(17):3632-3639.
42. Turgut B., Turgut N., Celik Y., Tekgunduz E., Pamuk G.E., Demir M. Differences in platelet-leukocyte aggregates among subtypes of acute cerebral ischemia. J. Neurol. Sci. 2011, 305(1-2):126-130.
43. Vila N., Castillo J., Davalos A., Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000, 31(10):2325-2329.